Chavant Capital Partners Discloses Stake in Mobix Labs

TL;DR

**Chavant Capital Partners just revealed a new stake in Mobix Labs, signaling potential institutional interest.**

AI Summary

Chavant Capital Partners LLC, led by Jiong Ma, filed an SC 13D on January 2, 2024, disclosing its ownership in Mobix Labs, Inc. Class A Common Stock. This filing indicates that Chavant Capital Partners LLC now holds a significant stake in Mobix Labs, Inc., with the event triggering this filing occurring on December 21, 2023. This matters to investors because it signals a notable institutional investor has taken a position in Mobix Labs, potentially indicating confidence in the company's future or a strategic interest.

Why It Matters

A new institutional investor, Chavant Capital Partners LLC, has taken a position in Mobix Labs, Inc., which could influence the stock's perception and future strategic direction.

Risk Assessment

Risk Level: low — This filing primarily discloses ownership and does not inherently introduce significant new risks, but rather provides transparency on an institutional investment.

Analyst Insight

A smart investor would monitor future filings from Chavant Capital Partners LLC regarding Mobix Labs, Inc. to understand their intentions (e.g., passive investment vs. activist stake) and assess any potential impact on Mobix Labs' stock performance.

Key Players & Entities

• Chavant Capital Acquisition Corp. (company) — subject company of the filing
• Chavant Capital Partners LLC (company) — entity filing the SC 13D
• Jiong Ma (person) — person authorized to receive notices and communications for Chavant Capital Partners LLC
• Mobix Labs, Inc. (company) — issuer of the Class A Common Stock
• December 21, 2023 (date) — date of event requiring the filing
• January 2, 2024 (date) — filing date of the SC 13D
• $0.00001 (dollar_amount) — par value per share of Mobix Labs, Inc. Class A Common Stock

Forward-Looking Statements

• Chavant Capital Partners LLC will increase its stake in Mobix Labs, Inc. (Chavant Capital Partners LLC) — low confidence, target: Q2 2024
• Mobix Labs, Inc. stock price will see increased volatility due to new institutional interest. (Mobix Labs, Inc.) — medium confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.00001 — suer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securiti
• $11.50 — se one share of Class A Common Stock at $11.50 per share and which will become exercis
• $0.0001 — reported as Ordinary Shares, par value $0.0001 per share (“ Ordinary Shares &rdq
• $25,000 — ed from Chavant for a purchase price of $25,000, or approximately $0.009 per share, on
• $0.009 — hase price of $25,000, or approximately $0.009 per share, on April 7, 2021 prior to th
• $1.00 — 11.50 per share, at an average price of $1.00 per warrant for an aggregate purchase p
• $2,794,332 — rant for an aggregate purchase price of $2,794,332. The warrants, which were converted int
• $10.00 — nsor PIPE Shares ”) at a price of $10.00 per share for an aggregate purchase pri
• $1,997,370 — hare for an aggregate purchase price of $1,997,370 paid through the forgiveness of the For
• $10.00 m — fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B)
• $7 — the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be
• $7.00 — stment Period VWAP will be deemed to be $7.00. In connection with the execution of t
• $0.01 — Stock ”) at an exercise price of $0.01 per share, exercisable upon the closing
• $12.00 — Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits
• $15.00 — Class A Common Stock equals or exceeds $15.00 per share (as adjusted for stock splits

Filing Documents

• tm2333981d2_sc13d.htm (SC 13D) — 79KB
• 0001104659-24-000323.txt ( ) — 81KB

From the Filing

SC 13D 1 tm2333981d2_sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Mobix Labs, Inc. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 60743G 100 (CUSIP Number) Jiong Ma 445 Park Avenue, 9 th Floor New York, New York, 10022 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 21, 2023 (Date of Event Which Requires Filing of this If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 60743G 100 1 NAMES OF REPORTING PERSONS Chavant Capital Partners LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC use only 4 Source of funds (SEE INSTRUCTIONS) OO 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Number of shares beneficially owned by each reporting person with 7 Sole Voting Power 1,394,101 (1) 8 Shared Voting Power 0 9 Sole Dispositive Power 1,394,101 (1) 10 Shared Dispositive Power 0 11 Aggregate Amount Beneficially Owned by Each Reporting Person 1,394,101 (1) 12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (SEE INSTRUCTIONS) 13 Percent of Class Represented by Amount in Row (11) 5.3%(2) 14 Type of Reporting Person (SEE INSTRUCTIONS) OO (1) Represents 1,394,101 shares of Class A Common Stock, par value $0.00001 per share (“ Class A Common Stock ”), of Mobix Labs, Inc. (the “ Issuer ”) held directly by Chavant Capital Partners LLC (the “ Sponsor ” or “ Chavant Capital ”) and indirectly beneficially owned by Dr. Jiong Ma, who is the sole member of Chavant Manager LLC, the manager of the Sponsor and has voting and dispositive power over the securities held directly by the Sponsor. As a result, Dr. Ma may be deemed to have beneficial except to the extent of her pecuniary interest therein. (2) Based on 26,376,280 shares of Class A Common Stock outstanding as of the closing of the Business Combination (as defined herein), as reported by the Issuer in its Current Report on Form 8-K filed on December 28, 2023 (the “ December 28 8-K ”). 2 CUSIP No. 60743G 100 1 NAMES OF REPORTING PERSONS Jiong Ma 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC use only 4 Source of funds (SEE INSTRUCTIONS) OO 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) 6 CITIZENSHIP OR PLACE OF ORGANIZATION United State of America Number of shares beneficially owned by each reporting person with 7 Sole Voting Power 2,635,653 (1) 8 Shared Voting Power 0 9 Sole Dispositive Power 2,635,653 (1) 10 Shared Dispositive Power 0 11 Aggregate Amount Beneficially Owned by Each Reporting Person 2,635,653 (1) 12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (SEE INSTRUCTIONS) 13 Percent of Class Represented by Amount in Row (11) 9.5%(2) 14 Type of Reporting Person (SEE INSTRUCTIONS) IN (1) Includes 1,394,101 shares of Class A Common Stock held by the Sponsor and 1,241,552 private placement warrants (the “ Warrants ”) held by Dr. Ma through a wholly-owned limited liability company, which are each exercisable to purchase one share of Class A Common Stock at $11.50 per share and which will become exercisable 30 days following December 21, 2023. Dr. Jiong Ma, who is the sole member of Chavant Manager LLC, the manager of the Sponsor and has voting and dispositive power over the securities held directly by the Sponsor. As a result, Dr. Ma may be deemed to have beneficial ownership of the securities directly held by the Sponsor. Dr. Ma disclaims any beneficial own

View Full Filing

View this SC 13D filing on SEC EDGAR